Ann Silk, MD, MS
SESSIONS
F049 Respect the Dormant Beast: Optimize Your Management of High-risk Cutaneous SCCs
Mar 8, 2025
•
3:30 PM - 5:30 PM
•
W208A
DISCLOSURES
GRAIL, INC – Stockholder Public Company(Stock); Illumina, Inc. – Stockholder Public Company(Stock); Merck – Advisory Board(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria);